CRISPR-Cas9 technology and its application in haematological disorders.

about

The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia.CRISPR/Cas9: the Jedi against the dark empire of diseases.

P2860

Q33688509-03C79E60-26B2-447F-A069-CB24893D92FD Q55263970-98AD3AA3-34DB-4192-AF1F-95D2E9B5FCCF

P2860

CRISPR-Cas9 technology and its application in haematological disorders.

Item

http://www.wikidata.org/entity/Q38822073

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

CRISPR-Cas9 technology and its application in haematological disorders.

@en

type

Item

label

CRISPR-Cas9 technology and its application in haematological disorders.

@en

prefLabel

CRISPR-Cas9 technology and its application in haematological disorders.

@en

P1476

CRISPR-Cas9 technology and its application in haematological disorders.

@en

P2093

Han Zhang

http://www.w3.org/2001/XMLSchema#string

Nami McCarty

http://www.w3.org/2001/XMLSchema#string

P2860

CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes

Genome engineering using the CRISPR-Cas9 system

CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes

A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae

Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi

RNA-guided human genome engineering via Cas9

Multiplex genome engineering using CRISPR/Cas systems

Efficient genome editing in zebrafish using a CRISPR-Cas system

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes

P304

208-225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14297

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

175

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27619566

http://www.w3.org/2001/XMLSchema#string

P921

CRISPR

P932

5889078

http://www.w3.org/2001/XMLSchema#string

CRISPR-Cas9 technology and its application in haematological disorders.

about

P2860

P2860

CRISPR-Cas9 technology and its application in haematological disorders.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932